Clinical trial
Randomized Placebo-controlled Phase II Cross-over Study on the Influence of Fampridine on Working Memory in Healthy Subjects
NCT04652557 is registered in ClinicalTrials.gov with Prof. Dominique de Quervain, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Placebo-controlled Phase II Cross-over Study on the Influence of Fampridine on Working Memory in Healthy Subjects
- Lead sponsor
- Prof. Dominique de Quervain, MD
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 1, 2021
- Completion date
- January 26, 2023
- Enrollment
- 44 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
working memory